![]() |
|
|
Vol. 288, Issue 3, 1334-1339, March 1999
Neuroscience Training Program (M.A.H., N.R.Z., G.A.G.), Departments
of
Psychiatry (G.A.G.) and
Pharmacology (N.R.Z., G.A.L., G.A.G.), and
the
Rocky Mountain Center for Sensor Technology (M.A.H., G.A.L.,
N.R.Z., G.A.G.), University of Colorado Health Sciences Center,
Denver, Colorado
In the present study, we used the potent cocaine analog
[3H]WIN 35,428 to map and quantify binding to the
dopamine transporter (DAT) within the dorsal striatum, nucleus
accumbens, substantia nigra, and ventral tegmental area in young
(6-month-old), middle-aged (12-month-old), and aged (18- and
24-month-old) Fischer 344 rats. Quantitative autoradiographic analysis
of indirect [3H]WIN 35,428 saturation curves revealed
two-site binding for all four brain regions in every age group. The
percentage of binding to the high- or low-affinity sites did not differ
with age or region and was approximately 50%. However, significant
age-related decreases in the overall density
(Bmax) of [3H]WIN
35,428-binding sites were observed in the striatum, nucleus accumbens,
substantia nigra, and ventral tegmental area. The
Bmax within all brain regions declined by
more than 15% every 6 months, with the Bmax
in the aged (24-month-old) group being approximately half that measured
in the young adult (6-month-old) group. Competition experiments
indicated that nomifensine also exhibited two-site binding to the DAT
in Fischer 344 rats. No consistent age-related differences in binding
affinities were noted with either [3H]WIN 35,428 or
nomifensine. Taken together, these results support the hypothesis that
functional DATs within the nigrostriatal and mesolimbic systems are
down-regulated with age, without changing their affinity for ligands.
This article has been cited by other articles:
![]() |
D. Herve, C. Le Moine, J.-C. Corvol, L. Belluscio, C. Ledent, A. A. Fienberg, M. Jaber, J.-M. Studler, and J.-A. Girault G{alpha}olf Levels Are Regulated by Receptor Usage and Control Dopamine and Adenosine Action in the Striatum J. Neurosci., June 15, 2001; 21(12): 4390 - 4399. [Abstract] [Full Text] [PDF] |
||||